Atlas Trials

An Observational Study of Treatment Patterns and Safety Outcomes for Metastatic or Locally Recurrent Breast Cancer (VIRGO)

Clinical trial NCT00726661 · COMPLETED

Trial details

NCT number
NCT00726661
Sponsor
Genentech, Inc.
Status
COMPLETED
Study type
OBSERVATIONAL
Breast Cancer
Start date
2008-06-01
Primary completion
2012-12-01
Enrollment
1287

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.